Arilvax

Arilvax®

Vaccinology A live-attenuated yellow fever vaccine. See Yellow fever.
Mentioned in ?
References in periodicals archive ?
Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial.
Reaccion cruzada en sueros de fiebre amarilla y dengue: desafios para el diagnostico
Powderject's smaller product lines also fared well with sales of yellow fever vaccine Arilvax up 70 per cent to pounds 3.2 million boosted by marketing.
Takeover talks at advanced stage
Powderject's smaller product lines also fared well with sales of its yellow fever vaccine Arilvax surging 70pc to pounds 3.2m boosted by increased marketing initiatives.
Takeover talks at buoyant Powderject
PHARMACEUTICAL firm Powderject has launched its yellow fever vaccine Arilvax, made in its Speke Evans Vaccines plant, in the Netherlands after its successful UK launch last year.
Business In Brief
The fall came after an announcement in the United States that approval of its yellow fever vaccine Arilvax has been delayed.
Medical firm's shares ailing
OraVax will be the exclusive United States marketer and distributor of Evans Medical Limited's yellow fever vaccine Arilvax once licensed in the United States.
OraVax receives United States patent for the use of a protein to detect highly virulent strains of Helicobacter pylori
Sales of TB vaccines performed well, while the yellow fever drug Arilvax made 'good progress'.
Vaccine specialist moves into the black

Medical browser ?
Full browser ?